These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17969224)

  • 21. Bush emergency relief promises US 7.5 billion dollars for HIV drugs.
    Morris K
    Lancet Infect Dis; 2003 Mar; 3(3):122. PubMed ID: 12614719
    [No Abstract]   [Full Text] [Related]  

  • 22. Are the best antiretrovirals being used in Africa?
    John L; Kambugu A; Songa PM; Castelnuovo B; Colebunders R; Kamya M
    J HIV Ther; 2006 Mar; 11(1):11-5. PubMed ID: 16706250
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV-1 care in resource-poor settings: a view from Haiti.
    Mukherjee JS
    Lancet; 2003 Sep; 362(9388):994-5. PubMed ID: 14513853
    [No Abstract]   [Full Text] [Related]  

  • 24. Scaling up antiretroviral treatment in resource-limited settings: successes and challenges.
    Katabira ET; Oelrichs RB
    AIDS; 2007 Jul; 21 Suppl 4():S5-10. PubMed ID: 17620753
    [No Abstract]   [Full Text] [Related]  

  • 25. Optimisation of HIV care and service delivery: doing more with less.
    Boyd MA; Cooper DA
    Lancet; 2012 Nov; 380(9856):1860-6. PubMed ID: 22828482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bridging the divide.
    El-Sadr WM; Rabkin M; Atun R; De Cock KM
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S59-60. PubMed ID: 21857296
    [No Abstract]   [Full Text] [Related]  

  • 27. Monitoring HIV treatment in the developing world.
    Kumarasamy N; Flanigan TP; Mahajan AP; Carpenter CC; Mayer KH; Solomon S
    Lancet Infect Dis; 2002 Nov; 2(11):656-7. PubMed ID: 12409043
    [No Abstract]   [Full Text] [Related]  

  • 28. Public health. Global HIV/AIDS policy in transition.
    Bongaarts J; Over M
    Science; 2010 Jun; 328(5984):1359-60. PubMed ID: 20538936
    [No Abstract]   [Full Text] [Related]  

  • 29. The human right to health, national courts, and access to HIV/AIDS treatment: a case study from Venezuela.
    Torres MA
    Chic J Int Law; 2002; 3(1):105-14. PubMed ID: 15709302
    [No Abstract]   [Full Text] [Related]  

  • 30. Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.
    Kent DM; McGrath D; Ioannidis JP; Bennish ML
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S13-24. PubMed ID: 12822128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cohort Profile: Antiretroviral Therapy in Lower Income Countries (ART-LINC): international collaboration of treatment cohorts.
    Dabis F; Balestre E; Braitstein P; Miotti P; Brinkhof WG; Schneider M; Schechter M; Laurent C; Boulle A; Kabugo C; Capkun G; Seyler C; McIntyre J; Sprinz E; Bangsberg D; Van der Borght S; Egger M;
    Int J Epidemiol; 2005 Oct; 34(5):979-86. PubMed ID: 16157617
    [No Abstract]   [Full Text] [Related]  

  • 32. Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries.
    Orsi F; d'almeida C
    Curr Opin HIV AIDS; 2010 May; 5(3):237-41. PubMed ID: 20539080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral treatments' durability and costs: important elements in the choice of first-line therapy.
    Restelli U; Croce D; Rizzardini G
    AIDS; 2016 Sep; 30(14):2247-9. PubMed ID: 27574794
    [No Abstract]   [Full Text] [Related]  

  • 34. Stirring the statistical pot.
    Bateman C
    S Afr Med J; 2004 Mar; 94(3):154-5. PubMed ID: 15098266
    [No Abstract]   [Full Text] [Related]  

  • 35. The discovery and development of antiretroviral agents.
    Lange JM; Ananworanich J
    Antivir Ther; 2014; 19 Suppl 3():5-14. PubMed ID: 25310317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Global Wicked Problem of Corruption and Its Risks for Access to HIV/AIDS Medicines.
    Kohler JC; Chang Pico T; Vian T; Mackey TK
    Clin Pharmacol Ther; 2018 Dec; 104(6):1054-1056. PubMed ID: 30076604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiretroviral drug development: the challenge of cost and access.
    Dunne M
    AIDS; 2007 Jul; 21 Suppl 4():S73-9. PubMed ID: 17620756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world.
    Tucker T; Yeats J
    S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766
    [No Abstract]   [Full Text] [Related]  

  • 39. Called to account.
    Aldhous P
    Nature; 2004 Jul; 430(6996):133. PubMed ID: 15241382
    [No Abstract]   [Full Text] [Related]  

  • 40. Access to HIV drugs: are we changing the two world paradigm?
    Lazzarini Z
    Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.